Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for researchers interested in exploring the ethical, legal, and social implications (ELSI) of biomedical research and health technologies. Eligible applicants typically include researchers at academic institutions, hospitals, research centers, and nonprofit organizations with institutional support and research infrastructure. The grant supports exploratory and developmental research projects that investigate ELSI questions relevant to NIH mission areas, including those related to clinical trials. Projects may be conducted domestically or internationally, and applicants must have an eligible institutional base. Individual researchers, research teams, and small research programs are welcome to apply. Organizations must have appropriate infrastructure to support the proposed research and administrative capabilities to manage federal funding.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. Direct involvement of key stakeholders where appropriate is encouraged. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- SF-424 (R&R) form and supporting forms (PHS 398 or equivalent)
- Project narrative / research plan (follow page limits in funding announcement)
- Detailed budget and budget justification
- Biographical sketches (NIH format) for all key personnel
- Institutional support letters and commitment documentation
- Letters of collaboration or support from partner institutions or experts
- Resources and environment description
- Data management plan (if applicable)
- Human subjects protection documentation (if applicable)
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.313 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$5,096,612
-
$2,994,561
-
$2,736,581
-
$2,735,186
-
$2,417,324
-
$1,332,345
-
$1,108,110
Top States by Funding
- TX 1 awards $5.1M
- GA 1 awards $3.0M
- NC 1 awards $2.7M
- MD 1 awards $2.7M
- MI 1 awards $2.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.313). How funding has trended year over year.
| 2024 | $48,892,335 | |
| 2025 | $54,230,732 | |
| 2026 est. | $52,202,393 |
FAQ
What types of ELSI research does this grant support?
This R21 grant supports exploratory and developmental research examining ethical, legal, and social questions related to biomedical science, health technologies, clinical research, and public health initiatives. Projects might examine privacy issues, equity in research, informed consent, health disparities, policy implications, and social impacts of emerging technologies.
Who is eligible to apply?
Researchers at accredited domestic and foreign institutions, including universities, medical schools, nonprofit organizations, and government agencies, are eligible. Applicants must hold a position at an NIH-eligible institution with institutional support and infrastructure to conduct the proposed work.
What is the typical funding amount and project duration?
R21 grants typically provide $150,000 to $300,000 in total costs over 2 years, though amounts vary by institute and complexity of proposed work. Check the specific NIH institute or center announcement for exact budget guidelines.
What documents are required in the application?
Standard NIH documents include the SF-424 (R&R) form, project narrative (not to exceed specified page limits), research plan, budget justification, institutional biosketches, and letters of support. Specific requirements vary; consult the funding announcement.
How competitive is this grant?
R21 grants are moderately competitive. Reviewers assess scientific innovation, feasibility of the exploratory approach, investigator qualifications, and significance of ELSI questions. Clear articulation of why the work is novel and timely strengthens competitiveness.
💡 Tips for applicants
- Ground your project in a genuine ELSI gap: clearly explain what ethical, legal, or social question is underexplored and why exploring it now matters for biomedical research or public health.
- Design a feasible exploratory scope: R21s support preliminary work, not full-scale studies. Focus on methods development, proof-of-concept, or early-stage inquiry that will inform future research.
- Demonstrate interdisciplinary collaboration: strong ELSI projects often involve bioethicists, legal scholars, social scientists, and subject-matter experts working together. Highlight complementary expertise on your team.
- Show institutional commitment: include letters of support from your institution and any partner organizations, demonstrating access to necessary resources and protected time for the research.
- Tailor to a specific NIH institute: different institutes have different ELSI priorities (e.g., NHGRI focuses on genomics ELSI, NIAAA on substance use ethics). Review the specific funding opportunity announcement to align your project.
⚠️ Common mistakes
Applications often fail to clearly articulate the specific ELSI gap or question being addressed, instead offering overly broad explorations of ethics without clear boundaries or relevance. Many proposals underestimate the complexity of ELSI research or submit projects that are too preliminary or unfocused for the R21 mechanism. Applicants frequently neglect to demonstrate serious institutional commitment or fail to include letters of support from collaborators, weakening the perceived feasibility of the proposed work.
Similar grants
- OPEN Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) — National Institutes of Health
- OPEN Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) — National Institutes of Health
- OPEN Research on the Ethical, Legal and Social Implications (ELSI) of Genomics — National Institutes of Health
- OPEN Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional — National Institutes of Health
- OPEN NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) — National Institutes of Health